Saks, Nordstrom, Ma...
Health Care: Drugs
Halozyme Therapeutics Inc. (HALO: NASDAQ)
$7.52 -0.05 | -0.66%
05/21/13 - 02:39 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with HALO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatch
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Contributor3 Stocks to Buy for Less Th...
- UserGFNN Stockdiagnostics 6
- ContributorStocks With Big Insider Buy...
- ContributorStocks At New 52-Week Highs...
Latest HALO Headlines from TheStreet
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Short Interest Increases 11.2% For HALO 05.10.13 | 03:05 pm
- 4 Under-$10 Stocks Making Big Moves 04.23.13 | 03:04 pm
- HALO Makes Bullish Cross Above Critical Moving Average 04.23.13 | 11:04 am
- 7 Stocks Under $10 Moving Higher 11.15.12 | 03:11 pm
- 5 Stocks With Big Insider Buying 08.29.12 | 11:08 am
- Halozyme Therapeutics Management Discusses Q2 2012 Results - Earnings Call Transcript 08.06.12 | 07:08 pm
- 5 Biotech Stocks Under $10 Set to Soar 07.19.12 | 11:07 am
Press Releases for HALO
- Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference - PR Newswire 05.07.13 | 04:05 pm
- Halozyme To Host First Quarter 2013 Financial Results Conference Call - PR Newswire 05.01.13 | 04:05 pm
- Halozyme Initiates Randomized Phase 2 Trial Of PEGPH20 In Pancreatic Cancer - PR Newswire 04.23.13 | 08:04 am
- Halozyme Therapeutics Names Matt Posard To Board Of Directors - PR Newswire 03.28.13 | 04:03 pm
- Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union - PR Newswire 03.22.13 | 08:03 am
- Halozyme Therapeutics To Present At The Barclays 2013 Global Healthcare Conference - PR Newswire 03.05.13 | 04:03 pm
- Halozyme To Host Fourth Quarter And 2012 Year-End Financial Results Conference Call - PR Newswire 02.19.13 | 04:02 pm
- Halozyme Therapeutics Issues Financial Guidance For 2013 - PR Newswire 01.07.13 | 07:01 am
- Halozyme Therapeutics To Present At The 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 04:01 pm
Partner Headlines for HALO
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus - Benzinga 03.22.13 | 04:03 pm
- Pertaining to Relief for ViroPharma - Analyst Blog - NASDAQ 09.25.12 | 07:09 pm
- ViroPharma Misses Zacks Estimates - Analyst Blog - Zacks 08.10.12 | 09:08 am
- VPHM Manufacturing Process Approved - Analyst Blog - Zacks 08.07.12 | 07:08 pm
- Bad News for ViroPharma - Analyst Blog - Zacks 08.03.12 | 06:08 pm
- After Hours Most Active for Aug 1, 2012 : SAN, GMCR, NOK, FSLR, BBVA, SBUX, BAC, JNJ, LEN, HALO, QQQ, SPLS - NASDAQ 08.01.12 | 08:08 pm
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Healthcare Biz Recap: GlaxoSmithKline BUYS Drugs, Sanofi Gains Traction - Wall St. Cheat Sheet 06.12.12 | 06:06 am
- Morning Market Losers - Benzinga 04.16.12 | 09:04 am
